AIM Vaccine Co., Ltd. Class H (HK:6660) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
AIM Vaccine Co., Ltd. has announced a board meeting scheduled for August 29, 2024, to discuss and approve the interim results for the first half of the year, consider a potential interim dividend, and conduct other business. The meeting comes as investors look to the company’s performance and strategic decisions during a period marked by global health challenges. The announcement was made by Chairman and CEO Mr. Yan ZHOU on August 19, 2024.
For further insights into HK:6660 stock, check out TipRanks’ Stock Analysis page.